COLANGELI, VINCENZO
COLANGELI, VINCENZO
Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain.
2024 Calza L, Giglia M, Colangeli V, Bon I, Vitale S, Viale P.
Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience.
2023 Calza L, Colangeli V, Pensalfine G, Appolloni L, Vitale S, Bon I, Viale P
Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir
2022 Calza L, Borderi M, Colangeli V, Miani T, Nuti B, Bon I, Lazzarotto T, Viale P
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy
2021 Calza L.; Bon I.; Tadolini M.; Borderi M.; Colangeli V.; Badia L.; Verucchi G.; Rossini G.; Vocale C.; Gaibani P.; Viale P.; Attard L.
COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection.
2021 Calza, L; Bon, I; Borderi, M; Colangeli, V; Borioni, A; Re, MARIA CARLA; Viale, P
No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide/emtricitabine plus raltegravir, dolutegravir or elvitegravir/cobicistat during a two-year follow-up
2020 Calza L, Borderi M, Colangeli V, Borioni A, Coladonato S, Granozzi B, Viale P
Prevalence of transmitted drug resistance mutations among newly diagnosed HIV-1-infected patients in a large teaching hospital of the Northern Italy
2020 Calza L, Tamburello M, Borderi M, Colangeli V, Testi D, Amedeo A, Re MC, Bon I
Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir
2020 Calza L.; Colangeli V.; Borderi M.; Bon I.; Borioni A.; Volpato F.; Re M.C.; Viale P.
Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study.
2019 Calza L, di Pietro G, Colangeli V, Borderi, Zaghi I, Malosso P, Bon I, Re MC, Viale P
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients
2019 Calza, Leonardo; Colangeli, Vincenzo; Borderi, Marco; Coladonato, Simona; Tazza, Beatrice; Bon, Isabella; Re, Maria Carla; Viale, Pierluigi
Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease.
2019 Calza L, Colangeli V, Borderi M, Coladonato S, Tazza B, Fornaro G, Badia L, Guardigni V, Verucchi G, Viale P.
Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy
2019 Calza L.; Sachs M.; Colangeli V.; Borderi M.; Granozzi B.; Malosso P.; Comai G.; Corradetti V.; La Manna G.; Viale P.
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia
2018 Calza, Leonardo*; Colangeli, Vincenzo; Borderi, Marco; Manfredi, Roberto; Marconi, Lorenzo; Bon, Isabella; Re, Maria Carla; Viale, Pierluigi
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection.
2017 Calza L, Colangeli V, Magistrelli E, Bussini L, Conti M, Ramazzotti E, Mancini R, Viale P.
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy
2017 Calza, Leonardo; Colangeli, Vincenzo; Magistrelli, Eleonora; Contadini, Ilaria; Bon, Isabella; Re, Maria Carla; Conti, Matteo; Mancini, Rita; Viale, Pierluigi
Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients
2016 Calza, Leonardo; Colangeli, Vincenzo; Manfredi, Roberto; Bon, Isabella; Re, Maria Carla; Viale, Pierluigi
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors
2016 Calza, Leonardo; Danese, Ilaria; Magistrelli, Eleonora; Colangeli, Vincenzo; Manfredi, Roberto; Bon, Isabella; Re, Maria Carla; Conti, Matteo; Viale, Pierluigi
HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): A three year study
2016 Musumeci, Giuseppina; Magnani, Giacomo; Bon, Isabella; Longo, Serena; Bertoldi, Alessia; Antoni, Anna Maria Degli; Rossi, Maria Rita; Ruggieri, Alessandro; Sambri, Vittorio; Semprini, Simona; Sighinolfi, Laura; Ursitti, Maria Alessandra; Zerbini, Alessandro; Colangeli, Vincenzo; Calza, Leonardo; Finarelli, ALBA-CAROLA; Massimiliani, Erika; Re, MARIA CARLA
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy
2016 Calza, Leonardo; Colangeli, Vincenzo; Magistrelli, Eleonora; Manfredi, Roberto; Bon, Isabella; Re, MARIA CARLA; Viale, Pierluigi
A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issues
2015 Manfredi R; Calza L; Marinacci G; Cascavilla A; Colangeli V; Salvadori C; Martelli G; Appolloni L; Puggioli C; Viale P